Literature DB >> 33486675

sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation.

Ruth Saez-Maleta1, Ana Merino-Merino2, Simon Gundin-Menendez1, Ricardo Salgado-Aranda2, Daniel AlKassam-Martinez1,3, Virginia Pascual-Tejerina2, Javier Martin-Gonzalez2, Javier Garcia-Fernandez2, Jose-Angel Perez-Rivera4,5.   

Abstract

Genotyping of ST2 and galectin-3 in atrial fibrillation (AF) is not well analyzed. The aim of our study was to analyze the possible relationship between levels of sST2 and galectin-3 and three polymorphisms in patients with AF. We included 125 patients with persistent AF undergoing electric cardioversion. We analyzed sST2 and galectin-3 levels and three polymorphisms in peripheral blood samples. Rs2274273 was significantly related with levels of galectin-3. Rs1558648 was associated with levels of sST2 but rs13019803 were not. None of the polymorphisms were connected to the variation of biomarkers levels during the follow up. We found a relationship between rs2274273 and galectin-3 levels and rs1558648 and sST2 levels in patients with AF.

Entities:  

Keywords:  Atrial fibrillation; Biomarkers; Galectin 3; Polymorphisms; sST2

Mesh:

Substances:

Year:  2021        PMID: 33486675     DOI: 10.1007/s11033-021-06150-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

Review 1.  ST2: a novel remodeling biomarker in acute and chronic heart failure.

Authors:  Ravi V Shah; James L Januzzi
Journal:  Curr Heart Fail Rep       Date:  2010-03

2.  Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.

Authors:  Roland R van Kimmenade; James L Januzzi; Patrick T Ellinor; Umesh C Sharma; Jaap A Bakker; Adrian F Low; Abelardo Martinez; Harry J Crijns; Calum A MacRae; Paul P Menheere; Yigal M Pinto
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

Review 3.  Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.

Authors:  Sheryl L Chow; Alan S Maisel; Inder Anand; Biykem Bozkurt; Rudolf A de Boer; G Michael Felker; Gregg C Fonarow; Barry Greenberg; James L Januzzi; Michael S Kiernan; Peter P Liu; Thomas J Wang; Clyde W Yancy; Michael R Zile
Journal:  Circulation       Date:  2017-04-26       Impact factor: 29.690

4.  Elevated soluble ST2 concentration may involve in the progression of atrial fibrillation.

Authors:  Xu Ma; Hui Yuan; Hai-Xia Luan; Ya-Li Shi; Xiao-Li Zeng; Yan Wang
Journal:  Clin Chim Acta       Date:  2018-02-08       Impact factor: 3.786

5.  The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.

Authors:  Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Tuncay Hazirolan; Lale Tokgozoglu; Mehmet A Oto; Necla Ozer; Dicle Guc; Kudret Aytemir
Journal:  J Cardiovasc Electrophysiol       Date:  2015-03-27

6.  Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease.

Authors:  Xiao-Yan Wu; Song-Nan Li; Song-Nan Wen; Jun-Gang Nie; Wen-Ning Deng; Rong Bai; Nian Liu; Ri-Bo Tang; Ting Zhang; Xin Du; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Europace       Date:  2015-04-28       Impact factor: 5.214

Review 7.  Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.

Authors:  Richard J Schilling
Journal:  Heart       Date:  2009-11-11       Impact factor: 5.994

8.  Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Oluwaseun E Fashanu; Faye L Norby; David Aguilar; Christie M Ballantyne; Ron C Hoogeveen; Lin Y Chen; Elsayed Z Soliman; Alvaro Alonso; Aaron R Folsom
Journal:  Am Heart J       Date:  2017-07-08       Impact factor: 4.749

9.  Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation.

Authors:  Sefa Okar; Onur Kaypakli; Durmuş Yıldıray Şahin; Mevlüt Koç
Journal:  Korean Circ J       Date:  2018-10       Impact factor: 3.243

10.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

Authors:  Shoji Sanada; Daihiko Hakuno; Luke J Higgins; Eric R Schreiter; Andrew N J McKenzie; Richard T Lee
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.